Immunovant, Inc.

Develops monoclonal antibody therapies for patients with autoimmune diseases.

Discussion

biotechpharmaceuticals

immunovant.com ↗

Company facts

Founded: 2018
Employees: 362
Headquarters: United States
Type: Public
Listed: NASDAQ: IMVT
Subsidiaries: IMVT Corporation

1 job

Posted Sort

1 job Posted Sort

Immunovant, Inc.

2 days ago

Senior Manager, Statistical Programming

NewBe an early applicant RemoteNorth AmericaContractSenior

United States

Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazers in FcRn inhibitor technology, the Company is boldly developing…

SAS Statistics XML

Apply